Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM)

Biochem Biophys Res Commun. 1995 Jun 26;211(3):833-9. doi: 10.1006/bbrc.1995.1887.

Abstract

Recent evidence suggests that expression of tumor necrosis factor-alpha (TNF-alpha) by adipocytes is a molecular mediator of insulin resistance in obesity. We have therefore tested the hypothesis that variations within the regulatory region of the TNF-alpha gene, which might cause increased adipocyte or generalized TNF-alpha synthesis, are associated with NIDDM, a state in which insulin resistance is routinely observed. Neither the previously known variants within the TNF-alpha promoter at position -308 and -238, nor two newly identified polymorphisms at position -376 and -163, were found at a significantly higher frequency in Caucasian NIDDM patients compared to non-diabetic controls. No genetic variants were found in Pima Indians. These data make it unlikely that mutations within regulatory elements of the TNF-alpha gene are associated with an increase in the prevalence of NIDDM.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Asian People / genetics
  • Base Sequence
  • Diabetes Mellitus, Type 2 / genetics*
  • Genetic Predisposition to Disease
  • Genetic Variation*
  • Humans
  • Indians, North American / genetics
  • Middle Aged
  • Molecular Sequence Data
  • Prevalence
  • Promoter Regions, Genetic / genetics*
  • Tumor Necrosis Factor-alpha / genetics*
  • White People / genetics

Substances

  • Tumor Necrosis Factor-alpha